Cogstate (ASX: CGS) Share Price

CGS

$2.74▼-0.36%

$465.5MRank #474 on ASXHealthcareMedical - Healthcare Information Services

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$465.5M

Volume

904K

P/E Ratio

20.94

EPS

$0.027

Dividend Yield

0.59%

52-Week High

$2.97

52-Week Low

$1.35

Beta

0.131

Cogstate (ASX: CGS) is an Australian-listed company in the Healthcare sector with a market capitalisation of $465.5M and the 474th-largest security on the ASX by market capitalisation. The CGS share price is $2.74, down 0.36% today and up 90.85% over the past 12 months. Shares have traded between $1.35 and $2.97 over the past 52 weeks. CGS trades on a price-to-earnings ratio of 20.94, above the Healthcare sector median of 14.96, and pays a trailing dividend yield of 0.59%. In its most recent reported period (ending 31 Dec 2025), Cogstate reported revenue of $39.3M and a net profit of $6.9M (17.6% margin).

Charts

$2.71

24H Range

$2.71

$2.765

52-Week Range

$1.35

$2.97

About Cogstate Limited

Melbourne, Australia-based Cogstate Limited, established in 1999, is a neuroscience technology company specializing in computerized cognitive assessments and digital solutions for clinical outcome evaluations. Its comprehensive suite of cognitive services includes project and data management, scientific consulting, statistical analysis, procurement of assessment scales, rater training, and monitoring solutions. The company operates through two distinct divisions. The Clinical Trials segment delivers technology and support services designed to measure the impact of diseases, pharmaceuticals, medical devices, or other interventions on human participants in clinical studies, primarily serving pharmaceutical and biotechnology clients. Concurrently, its Healthcare segment offers Cognigram, a system facilitating regular and standardized testing to assist primary care physicians and hospitals in the early identification of cognitive decline. By June 30, 2022, Cogstate had participated in an estimated 1,800 academic research initiatives.

IPO Date

12 Feb 2004

CEO

Bradley John O'Connor

Employees

147

Website

cogstate.com

Key Financial Data

Revenue (Quarterly)	$39.3M
Net Income (Quarterly)	$6.9M
Total Assets	$102.0M
Total Debt	$1.1M
Free Cash Flow	$3.8M
Return on Equity	8.94%
Profit Margin	17.59%
Operating Margin	14.04%

CGS Frequently Asked Questions

What is the Cogstate (ASX: CGS) share price?

The CGS share price is $2.74, down 0.36% for the day, based on the latest available ASX market data.

What is Cogstate's market capitalisation?

Cogstate has a market capitalisation of $465.5M, making it the 474th-largest security listed on the ASX.

Does Cogstate pay a dividend?

Yes. CGS has a trailing dividend yield of 0.59%.

What is CGS's P/E ratio?

Cogstate trades on a trailing price-to-earnings (P/E) ratio of 20.94, based on its current share price and most recent reported earnings.

Is Cogstate profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), CGS reported revenue of $39.3M and a net profit of $6.9M.

How many CGS shares are on issue?

Cogstate has approximately 169,884,352 shares on issue, based on its market capitalisation of $465.5M and current share price.

What sector is Cogstate in?

Cogstate is classified in the Healthcare sector, within the Medical - Healthcare Information Services industry on the ASX.

When did Cogstate list on the ASX?

Cogstate listed on the Australian Securities Exchange on 12 Feb 2004.

Latest News

Kalkine ASX News: Cogstate Ltd (ASX:CGS) Pushes Higher as Healthcare Tech Momentum Build

Kalkine Media10 June 2026

Kalkine ASX News: Cogstate Ltd (ASX:CGS) Pushes Higher as Healthcare Tech Momentum Build Kalkine Media

ASX Stocks That May Be Trading Below Fair Value In May 2026

simplywall.st24 May 2026

ASX Stocks That May Be Trading Below Fair Value In May 2026 simplywall.st

Insights: CogState Ltd (ASX:CGS)

smallcaps.com.au30 Oct 2025

Insights: CogState Ltd (ASX:CGS) smallcaps.com.au

ALERT: Price-sensitive ASX Announcement for CGS

intelligentinvestor.com.au22 Jan 2026

ALERT: Price-sensitive ASX Announcement for CGS intelligentinvestor.com.au

Bell Potter names the best ASX shares to buy in March

The Motley Fool Australia7 Mar 2026

Bell Potter names the best ASX shares to buy in March The Motley Fool Australia

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
AYAArtrya Limited	$512.1M	$4.50	-13.78	0.00%	▼-4.26%
CUVClinuvel Pharmaceuticals Limited	$451.7M	$8.96	14.96	0.40%	▲+1.24%
IMRImricor Medical Systems, Inc.	$436.7M	$1.75	-6.61	0.00%	▲+4.17%
OCAOceania Healthcare Limited	$420.1M	$0.58	-26.28	0.00%	▲+0.87%
ACLAustralian Clinical Labs Limited	$405.4M	$2.16	23.92	3.29%	–+0.00%
AFPAFT Pharmaceuticals Limited	$321.9M	$3.07	7.71	0.00%	▼-5.54%
PGCParagon Care Limited	$248.3M	$0.15	-4.18	0.00%	▼-3.23%
MYXMayne Pharma Group Limited	$195.8M	$2.41	-4.23	0.00%	▼-2.03%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.75	$2.765	$2.71	$2.71	899K	▼-1.45%
11 June 2026	$2.81	$2.81	$2.705	$2.75	248K	▼-2.14%
10 June 2026	$2.59	$2.85	$2.57	$2.81	915K	▲+8.91%
9 June 2026	$2.50	$2.58	$2.36	$2.58	90K	▲+2.79%
8 June 2026	$2.52	$2.54	$2.48	$2.51	121K	▲+0.40%
5 June 2026	$2.52	$2.54	$2.48	$2.50	119K	–+0.00%
4 June 2026	$2.52	$2.55	$2.48	$2.50	59K	▼-0.40%
3 June 2026	$2.46	$2.525	$2.44	$2.51	165K	▲+3.29%
2 June 2026	$2.56	$2.56	$2.42	$2.43	156K	▼-4.71%
1 June 2026	$2.63	$2.63	$2.53	$2.55	51K	–+0.00%
29 May 2026	$2.60	$2.60	$2.53	$2.55	184K	▼-1.92%
28 May 2026	$2.635	$2.635	$2.59	$2.60	83K	▼-0.76%
27 May 2026	$2.55	$2.64	$2.55	$2.62	180K	▲+1.95%
26 May 2026	$2.61	$2.62	$2.545	$2.57	25K	▼-1.15%
25 May 2026	$2.64	$2.64	$2.57	$2.60	90K	▼-0.95%
22 May 2026	$2.53	$2.645	$2.53	$2.625	162K	▲+2.94%
21 May 2026	$2.51	$2.58	$2.51	$2.55	33K	▲+1.19%
20 May 2026	$2.60	$2.64	$2.52	$2.52	19K	▼-0.40%
19 May 2026	$2.52	$2.61	$2.52	$2.53	126K	▲+0.80%
18 May 2026	$2.48	$2.52	$2.47	$2.51	816K	▼-0.40%
15 May 2026	$2.53	$2.54	$2.49	$2.52	30K	–+0.00%
14 May 2026	$2.48	$2.55	$2.45	$2.52	64K	▲+2.86%
13 May 2026	$2.40	$2.52	$2.40	$2.45	42K	▼-0.41%
12 May 2026	$2.50	$2.50	$2.43	$2.46	76K	▲+0.41%
11 May 2026	$2.34	$2.46	$2.34	$2.45	41K	▲+3.38%
8 May 2026	$2.38	$2.38	$2.27	$2.37	88K	–+0.00%
7 May 2026	$2.40	$2.40	$2.32	$2.37	101K	▲+0.85%
6 May 2026	$2.32	$2.40	$2.32	$2.35	19K	–+0.00%
5 May 2026	$2.40	$2.41	$2.35	$2.35	37K	▼-3.69%
4 May 2026	$2.38	$2.47	$2.37	$2.44	91K	▲+0.83%

About Cogstate Limited

IPO Date

12 Feb 2004

CEO

Bradley John O'Connor

Employees

147

Website

cogstate.com

CGS Frequently Asked Questions

What is the Cogstate (ASX: CGS) share price?

The CGS share price is $2.74, down 0.36% for the day, based on the latest available ASX market data.

What is Cogstate's market capitalisation?

Cogstate has a market capitalisation of $465.5M, making it the 474th-largest security listed on the ASX.

Does Cogstate pay a dividend?

Yes. CGS has a trailing dividend yield of 0.59%.

What is CGS's P/E ratio?

Cogstate trades on a trailing price-to-earnings (P/E) ratio of 20.94, based on its current share price and most recent reported earnings.

Is Cogstate profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), CGS reported revenue of $39.3M and a net profit of $6.9M.

How many CGS shares are on issue?

Cogstate has approximately 169,884,352 shares on issue, based on its market capitalisation of $465.5M and current share price.

What sector is Cogstate in?

Cogstate is classified in the Healthcare sector, within the Medical - Healthcare Information Services industry on the ASX.

When did Cogstate list on the ASX?

Cogstate listed on the Australian Securities Exchange on 12 Feb 2004.

Company

Market Cap

Price

P/E

Div Yield

1D Change

AYAArtrya Limited

$512.1M

$4.50

-13.78

0.00%

▼-4.26%

CUVClinuvel Pharmaceuticals Limited

$451.7M

$8.96

14.96

0.40%

▲+1.24%

IMRImricor Medical Systems, Inc.

$436.7M

$1.75

-6.61

0.00%

▲+4.17%

OCAOceania Healthcare Limited

$420.1M

$0.58

-26.28

0.00%

▲+0.87%

ACLAustralian Clinical Labs Limited

$405.4M

$2.16

23.92

3.29%

–+0.00%

AFPAFT Pharmaceuticals Limited

$321.9M

$3.07

7.71

0.00%

▼-5.54%

PGCParagon Care Limited

$248.3M

$0.15

-4.18

0.00%

▼-3.23%

MYXMayne Pharma Group Limited

$195.8M

$2.41

-4.23

0.00%

▼-2.03%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.75	$2.765	$2.71	$2.71	899K	▼-1.45%
11 June 2026	$2.81	$2.81	$2.705	$2.75	248K	▼-2.14%
10 June 2026	$2.59	$2.85	$2.57	$2.81	915K	▲+8.91%
9 June 2026	$2.50	$2.58	$2.36	$2.58	90K	▲+2.79%
8 June 2026	$2.52	$2.54	$2.48	$2.51	121K	▲+0.40%
5 June 2026	$2.52	$2.54	$2.48	$2.50	119K	–+0.00%
4 June 2026	$2.52	$2.55	$2.48	$2.50	59K	▼-0.40%
3 June 2026	$2.46	$2.525	$2.44	$2.51	165K	▲+3.29%
2 June 2026	$2.56	$2.56	$2.42	$2.43	156K	▼-4.71%
1 June 2026	$2.63	$2.63	$2.53	$2.55	51K	–+0.00%
29 May 2026	$2.60	$2.60	$2.53	$2.55	184K	▼-1.92%
28 May 2026	$2.635	$2.635	$2.59	$2.60	83K	▼-0.76%
27 May 2026	$2.55	$2.64	$2.55	$2.62	180K	▲+1.95%
26 May 2026	$2.61	$2.62	$2.545	$2.57	25K	▼-1.15%
25 May 2026	$2.64	$2.64	$2.57	$2.60	90K	▼-0.95%
22 May 2026	$2.53	$2.645	$2.53	$2.625	162K	▲+2.94%
21 May 2026	$2.51	$2.58	$2.51	$2.55	33K	▲+1.19%
20 May 2026	$2.60	$2.64	$2.52	$2.52	19K	▼-0.40%
19 May 2026	$2.52	$2.61	$2.52	$2.53	126K	▲+0.80%
18 May 2026	$2.48	$2.52	$2.47	$2.51	816K	▼-0.40%
15 May 2026	$2.53	$2.54	$2.49	$2.52	30K	–+0.00%
14 May 2026	$2.48	$2.55	$2.45	$2.52	64K	▲+2.86%
13 May 2026	$2.40	$2.52	$2.40	$2.45	42K	▼-0.41%
12 May 2026	$2.50	$2.50	$2.43	$2.46	76K	▲+0.41%
11 May 2026	$2.34	$2.46	$2.34	$2.45	41K	▲+3.38%
8 May 2026	$2.38	$2.38	$2.27	$2.37	88K	–+0.00%
7 May 2026	$2.40	$2.40	$2.32	$2.37	101K	▲+0.85%
6 May 2026	$2.32	$2.40	$2.32	$2.35	19K	–+0.00%
5 May 2026	$2.40	$2.41	$2.35	$2.35	37K	▼-3.69%
4 May 2026	$2.38	$2.47	$2.37	$2.44	91K	▲+0.83%